Balloon Device Import Ban Draws Public Comment
Published Date: 7/2/2026
Notice
Summary
The U.S. International Trade Commission is asking the public for their thoughts on a possible ban and stop-sale orders for certain balloon dilation devices linked to companies like Fiagon and Hemostasis. If the ban happens, it could affect imports and sales of these medical devices in the U.S., so your input matters! This is a chance to weigh in before any final decisions, with no immediate money changes yet but potential impacts ahead.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 1 costs, 0 mixed.
Possible U.S. ban on balloon devices
The Commission is considering a limited exclusion order and cease-and-desist orders that would block certain balloon dilation devices, systems, and components imported or sold by Fiagon GmbH, Fiagon NA, LLC, or Hemostasis, LLC from entry into the United States. The ALJ issued a Final Initial Determination on Violation on June 26, 2026, and the Commission is asking for public comments (up to five pages) by July 30, 2026 about how those orders would affect public health, U.S. consumers, and competitive conditions.
Opportunity for U.S. makers to replace devices
The Commission is asking whether U.S.-made like or directly competitive balloon dilation articles exist that could replace the devices if the recommended orders are issued, and whether complainant, licensees, or third-party suppliers could replace the volume within a commercially reasonable time. Comments (no more than five pages) are due by July 30, 2026 and should address domestic production capacity to replace the potentially excluded imports.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16811, Certain Ink Cartridges and Components Thereof II; Notice of a Commission Determination Finding a Violation Under Section 337; Issuance of a General Exclusion Order and Cease and Desist Orders; Termination of the Investigation
Notice is hereby given that the U.S. International Trade Commission has determined to find a violation under section 337 of the Tariff Act of 1930, as amended, and to issue a general exclusion order ("GEO") prohibiting the importation of products that infringe claims 1 and 7 of each of the following patents: U.S. Patent Nos. 8,764,172 ("the '172 patent"); 9,370,934 ("the '934 patent"); 11,535,038 ("the '038 patent"); 12,240,248 ("the '248 patent"); and 12,240,249 ("the '249 patent"); and cease and desist orders ("CDOs") against respondents Mountain Peak, Inc. and Straightouttaink, LP. The investigation is terminated.
2026-16816, Hand Trucks and Certain Parts Thereof From China; Determination
2026-16581, Carbazole Violet Pigment 23 From China and India; Termination of Five-Year Reviews
The Commission instituted the subject five-year reviews on May 1, 2026 to determine whether revocation of the countervailing duty order on carbazole violet pigment 23 from India and the antidumping duty orders on carbazole violet pigment 23 from China and India would be likely to lead to continuation or recurrence of material injury. On August 7, 2026, the Department of Commerce published notice in the Federal Register that it was revoking the orders applicable August 7, 2026, because no domestic interested party filed a timely notice of intent to participate. Accordingly, the subject reviews are terminated.
2026-16667, Certain Mobile Electronic Devices; Notice of Institution of Investigation
Notice is hereby given that a complaint was filed with the U.S. International Trade Commission on July 10, 2026, under section 337 of the Tariff Act of 1930, as amended, on behalf of Maxell, Ltd. of Kyoto, Japan. An amended complaint was filed on July 24, 2026. The amended complaint alleges violations of section 337 based upon the importation into the United States, the sale for importation, and the sale within the United States after importation of certain mobile electronic devices by reason of the infringement of certain claims of U.S. Patent No. 10,812,646 ("the '646 patent"); U.S. Patent No. 12,513,408 ("the '408 patent"); U.S. Patent No. 12,061,760 ("the '760 patent"); U.S. Patent No. 12,418,692 ("the '692 patent"); U.S. Patent No. 12,185,211 ("the '211 patent"); and U.S. Patent No. 12,647,935 ("the '935 patent"). The amended complaint further alleges that an industry in the United States exists as required by the applicable Federal Statute. The amended complainant requests that the Commission institute an investigation and, after the investigation, issue a limited exclusion order and cease and desist orders.
2026-16469, Choline Salts From China; Determinations
The U.S. International Trade Commission found that imports of choline salts from China might be hurting American businesses by being sold unfairly cheap and getting government help. This means a deeper investigation is starting soon, which could lead to new rules or tariffs to protect U.S. companies. If you’re involved in this industry, keep an eye out for updates and possible changes that could affect prices and trade.
2026-16302, Large Vertical Shaft Engines From China; Determinations
Previous / Next Documents
Previous: 2026-13433, Submission for Review: Application for Refund of Retirement Deductions (CSRS)-SF 2802 and Current/Former Spouse's Notification for Refund of Retirement Deductions Under CSRS-SF 2802A, 3206-0128
If you or your current/former spouse paid into the Civil Service Retirement System (CSRS), you might be able to get some of that money back! The Office of Personnel Management is asking for public feedback on the forms used to apply for these refunds before they update them. You’ve got until August 3, 2026, to share your thoughts and make sure the process stays smooth and easy.
Next: 2026-13435, Certain Systems, Devices, Software, Compositions, Chemicals, and Laboratory Supplies for Studying Proteins; Notice of Institution of Investigation
The U.S. International Trade Commission is starting an investigation because Seer, Inc. and Brigham and Women's Hospital say some imported protein research tools are breaking their patents. This could lead to stopping those products from being sold in the U.S., affecting companies that make or sell these tools. The investigation kicks off now and could impact the market and money flow in this field soon.